Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to determine if 12 weeks of treatment with LY2484595 administered as a monotherapy will significantly increase high-density lipoprotein cholesterol (HDL-C) and decrease low-density lipoprotein cholesterol (LDL-C) in Japanese participants.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Have Low HDL-C or High LDL-C criteria as follows:
Low HDL lipid criteria:
HDL-C <45 milligrams per deciliter (mg/dL) (men) and <50 mg/dL (women), and
LDL-C according to Japan Atherosclerosis Society (JAS) guidelines as follows:
Fasting Triglycerides (TG) <400 mg/dL
or
High LDL-C lipid criteria:
HDL-C <100 mg/dL, and
LDL-C according to JAS guidelines as follows:
Fasting TG <400 mg/dL
Note: Subjects with diabetes regarded as 3+ risk factors
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
165 participants in 6 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal